AMERGE

This brand name is authorized in Canada, Japan, United States

Active ingredients

The drug AMERGE contains one active pharmaceutical ingredient (API):

1 Naratriptan UNII 10X8X4P12Z - NARATRIPTAN HYDROCHLORIDE

Naratriptan has been shown to be a selective agonist for 5 hydroxytryptamine1 (5-HT1) receptors mediating vascular contraction. This receptor is found predominantly in intracranial (cerebral and dural) blood vessels. Naratriptan is indicated for the acute treatment of migraine attacks with or without aura. Read about Naratriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMERGE Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC02	Naratriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02237820, 02237821
Country: JP	医薬品医療機器総合機構	Identifier(s): 2160007F1020
Country: US	FDA, National Drug Code	Identifier(s): 0173-0561, 0173-0562